๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this research study is to determine the effect of chronic ni...
Status
Completed
Location
University of Louisville
Start Date
2003-01
Trial ID
NCT00310323
Treatments Being Tested
Cytochromes P450, main enzymes of drug metabolism, play a prominent role in...
Status
Unknown
Location
Geneva University Hospitals, HUG
Start Date
2017-09-01
Trial ID
NCT03262051
Treatments Being Tested
Higher doses of rifampicin as a means of more efficient use of this pivotal...
Status
Completed
Location
TASK
Start Date
2021-01-07
Trial ID
NCT04525235
Treatments Being Tested
The purpose of this study is to assess how the pharmacokinetic profiles of ...
Status
Completed
Location
Phase I Research Unit, University Hospital
Start Date
2011-05
Trial ID
NCT01386593
CYP2D6 metabolizes \~25% of all marketed drugs. There is an important varia...
Status
Completed
Location
HUG
Start Date
2019-01-01
Trial ID
NCT04188028
Treatments Being Tested
The hypothesis is to test to see if the drug fenofibrate will increase impo...
Status
Completed
Location
Vanderbilt University
Start Date
2009-09
Trial ID
NCT00872599
Treatments Being Tested
The purpose of the study is to understand the effect of rhGH therapy on hep...
Status
Completed
Location
University of California at San Diego
Start Date
2001-06
Trial ID
NCT00458991
Treatments Being Tested
Aim of work: 1. To estimate the frequency of Cyp2D6\*1 and \*4 alleles in ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-09-01
Trial ID
NCT03582865
Treatments Being Tested
The objective of this clinical trial is to identify endogenous compounds (s...
Status
Recruiting
Location
The Geneva University Hospitals (HUG)
Start Date
2024-12-05
Trial ID
NCT07014930
Treatments Being Tested